Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.
about
Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@en
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@nl
type
label
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@en
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@nl
prefLabel
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@en
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@nl
P2093
P2860
P356
P1476
Role of the BrafV637E mutation ...... amine in neonatal B6C3F1 mice.
@en
P2093
Hiroki Tanaka
Katsuhiro Ogawa
Keiko Shimizu
Kosuke Yamazaki
Masahiro Yamamoto
Yuji Nishikawa
P2860
P304
P356
10.1002/MC.22510
P577
2016-06-02T00:00:00Z